Alternatively, MICA could act as a minor histocompatibility antigen, i.e., a source for polymorphic peptides presented by cognate and/or donor MHC class I molecules and hence participate in the GVHD pathophysiology through its contribution to alloreactivity. The gene discussed is MICA; the disease is graft versus host disease.